Helicobacter Infections

• 

  Subject Areas on Research

  • A Predictive Model of Noncardia Gastric Adenocarcinoma Risk Using Antibody Response to Helicobacter pylori Proteins and Pepsinogen. 
  • A Prospective Study of Urinary Prostaglandin E2 Metabolite, Helicobacter pylori Antibodies, and Gastric Cancer Risk. 
  • A community screening program for Helicobacter pylori saves money: 10-year follow-up of a randomized controlled trial. 
  • A pilot study of Helicobacter pylori infection and risk of laryngopharyngeal cancer. 
  • AGA Institute Quality Measure Development for the Management of Gastric Intestinal Metaplasia With Helicobacter pylori. 
  • Acceptance of repeat esophagogastroduodenoscopy to detect gastric cancer in a Chinese immigrant cohort. 
  • Adverse events with bismuth salts for Helicobacter pylori eradication: systematic review and meta-analysis. 
  • Aetiopathogenesis of functional dyspepsia. 
  • An Approach to the Primary and Secondary Prevention of Gastric Cancer in the United States. 
  • An Updated Approach to Evaluation and Treatment of Helicobacter pylori Infection. 
  • Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue. An uncontrolled trial. 
  • Association of Helicobacter pylori and Autoimmune Gastritis With Stomach Cancer in a Cohort of Young Finnish Women. 
  • Association of Helicobacter pylori infection and diet on the risk of gastric cancer: a case-control study in Hawaii. 
  • Barrett's esophagus in 2008: an update. 
  • Chemoprevention for gastric cancer. 
  • Circulating cytokines and gastric cancer risk. 
  • Clinical trial: knowledge of negative Helicobacter pylori status reduces subsequent dyspepsia-related resource use. 
  • Current guidelines for dyspepsia management. 
  • Detection of Helicobacter pylori gastritis by PCR: correlation with inflammation scores and immunohistochemical and CLOtest findings. 
  • Diet, Helicobacter pylori strain-specific infection, and gastric cancer risk among Chinese men. 
  • Differences in antibody levels to H. pylori virulence factors VacA and CagA among African Americans and whites in the Southeast USA. 
  • Difluoromethylornithine is a novel inhibitor of Helicobacter pylori growth, CagA translocation, and interleukin-8 induction. 
  • Does Helicobacter pylori really cause duodenal ulcers? Yes. 
  • Dyspepsia. 
  • Effect of dyspepsia on survival: a longitudinal 10-year follow-up study. 
  • Effect of sibling number in the household and birth order on prevalence of Helicobacter pylori: a cross-sectional study. 
  • Effectiveness of management strategies for uninvestigated dyspepsia: systematic review and network meta-analysis. 
  • Effects of Helicobacter infection on research: the case for eradication of Helicobacter from rodent research colonies. 
  • Epidemiology of Helicobacter pylori infection and public health implications. 
  • Eradicating Helicobacter pylori in functional dyspepsia. 
  • Eradicating Multi-Drug-Resistant Helicobacter pylori with Four Times Daily Lansoprazole. 
  • Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients. 
  • Eradication therapy for peptic ulcer disease in Helicobacter pylori-positive people. 
  • Eradication therapy in Helicobacter pylori positive peptic ulcer disease: systematic review and economic analysis. 
  • Fluctuation of gastrointestinal symptoms in the community: a 10-year longitudinal follow-up study. 
  • Follow-up care after a diagnosis of Helicobacter pylori infection in an Asian immigrant cohort. 
  • Fragment-Based De Novo Design Reveals a Small-Molecule Inhibitor of Helicobacter Pylori HtrA. 
  • Fruit and vegetable consumption, Helicobacter pylori antibodies, and gastric cancer risk: A pooled analysis of prospective studies in China, Japan, and Korea. 
  • Functional Dyspepsia. 
  • Functional dyspepsia. 
  • Gastric cancer: an infectious disease. 
  • Genomic and Epigenomic Profiling of High-Risk Intestinal Metaplasia Reveals Molecular Determinants of Progression to Gastric Cancer. 
  • Helicobacter canis bacteremia in a patient with fever of unknown origin. 
  • Helicobacter infection decreases reproductive performance of IL10-deficient mice. 
  • Helicobacter pylori "test and treat" or endoscopy for managing dyspepsia: an individual patient data meta-analysis. 
  • Helicobacter pylori Biomarkers and Risk of Colorectal Oncogenesis--Response. 
  • Helicobacter pylori Blood Biomarkers and Gastric Cancer Survival in China. 
  • Helicobacter pylori and colorectal cancer-A bacterium going abroad? 
  • Helicobacter pylori blood biomarker for gastric cancer risk in East Asia. 
  • Helicobacter pylori eradication for the prevention of gastric neoplasia. 
  • Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trials. 
  • Helicobacter pylori eradication therapy to prevent gastric cancer: systematic review and meta-analysis. 
  • Helicobacter pylori eradication. 
  • Helicobacter pylori prevalence and circulating micronutrient levels in a low-income United States population. 
  • Helicobacter pylori protein-specific antibodies and risk of colorectal cancer. 
  • Helicobacter pylori stimulates gastric epithelial cell MMP-1 secretion via CagA-dependent and -independent ERK activation. 
  • Helicobacter pylori test and treat versus proton pump inhibitor in initial management of dyspepsia in primary care: multicentre randomised controlled trial (MRC-CUBE trial). 
  • Helicobacter pylori-associated peptic ulcer disease: A retrospective analysis of post-treatment testing practices. 
  • Helicobacter typhlonius and Helicobacter rodentium differentially affect the severity of colon inflammation and inflammation-associated neoplasia in IL10-deficient mice. 
  • Hit or a miss: Concordance between histopathologic-endoscopic findings in gastric mucosal biopsies. 
  • Immunostimulatory membrane proteins potentiate H. pylori-induced carcinogenesis by enabling CagA translocation. 
  • Increasing Testing for Helicobacter pylori Infection to Improve Quality of Patient Care. 
  • Initial management strategies for dyspepsia. 
  • Interleukin-1B gene promoter variants are associated with an increased risk of gastric cancer in a Chinese population. 
  • Irritable bowel syndrome: a 10-yr natural history of symptoms and factors that influence consultation behavior. 
  • Isolation and characterization of a novel Helicobacter species, Helicobacter jaachi sp. nov., from common marmosets (Callithrix jaachus). 
  • Leptin and ghrelin in relation to Helicobacter pylori status in adult males. 
  • Long-Term Impact of Helicobacter pylori Eradication Therapy on Gastric Cancer Incidence and Mortality in Healthy Infected Individuals: A Meta-Analysis Beyond 10 Years of Follow-Up. 
  • Managing dyspepsia. 
  • Meta-analysis: Helicobacter pylori'test and treat' compared with empirical acid suppression for managing dyspepsia. 
  • Neighborhood socio-economic characteristics, African ancestry, and Helicobacter pylori sero-prevalence. 
  • Neonatal co-infection with helicobacter species markedly accelerates the development of inflammation-associated colonic neoplasia in IL-10(-/-) mice. 
  • Optimum duration of regimens for Helicobacter pylori eradication. 
  • Performance of multiplex serology in discriminating active vs past Helicobacter pylori infection in a primarily African American population in the southeastern United States. 
  • Polymorphisms of the DNA repair gene XRCC1 and risk of gastric cancer in a Chinese population. 
  • Population screening and treatment of Helicobacter pylori infection. 
  • Prevalence of Helicobacter pylori infection and associated factors among adults in Southern Brazil: a population-based cross-sectional study. 
  • Prospective study of Helicobacter pylori biomarkers for gastric cancer risk among Chinese men. 
  • Race, African ancestry, and Helicobacter pylori infection in a low-income United States population. 
  • Redundant data in the meta-analysis on Helicobacter pylori eradication. 
  • Review: Prevention and management of gastric cancer. 
  • Serologic Response to Helicobacter pylori Proteins Associated With Risk of Colorectal Cancer Among Diverse Populations in the United States. 
  • Serum Pepsinogen as a Biomarker for Gastric Cancer in the United States: A Nested Case-Control Study Using the PLCO Cancer Screening Trial Data. 
  • Smoking, Helicobacter Pylori Serology, and Gastric Cancer Risk in Prospective Studies from China, Japan, and Korea. 
  • Systematic review with meta-analysis: association of Helicobacter pylori infection with gastro-oesophageal reflux and its complications. 
  • The Durham Initiative for Stomach Health (DISH): a pilot community-based Helicobacter pylori education and screening study. 
  • The U-shaped association between body mass index and gastric cancer risk in the Helicobacter pylori Biomarker Cohort Consortium: A nested case-control study from eight East Asian cohort studies. 
  • The development of therapeutic and preventive vaccines for gastric cancer and Helicobacter pylori. 
  • The effect of H. pylori eradication on meal-associated changes in plasma ghrelin and leptin. 
  • The incidence of Helicobacter pylori in patients with interstitial cystitis. 
  • The natural history of gastro-oesophageal reflux symptoms in the community and its effects on survival: a longitudinal 10-year follow-up study. 
  • Treatment of Helicobacter pylori in Latin America. 
  • WITHDRAWN: Initial management strategies for dyspepsia. 
  • Whom should we "test and treat" for Helicobacter pylori? 
  • [Relationship between Helicobacter pylori infection and miR-24-3p expression during the development of gastric mucosa lesions].